UA41446C2 - Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі - Google Patents

Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі

Info

Publication number
UA41446C2
UA41446C2 UA97094765A UA97094765A UA41446C2 UA 41446 C2 UA41446 C2 UA 41446C2 UA 97094765 A UA97094765 A UA 97094765A UA 97094765 A UA97094765 A UA 97094765A UA 41446 C2 UA41446 C2 UA 41446C2
Authority
UA
Ukraine
Prior art keywords
fumagilol
derivatives
pharmaceutical composition
intestinal infection
drugs intended
Prior art date
Application number
UA97094765A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жан-Мішель Моліна
Жан-Мишель Молина
Франсіс Деруен
Френсис Деруэн
Original Assignee
Санофі - Сінтелабо
Санофи-Синтелабо
Ассістанс Пюблік-Опіто Де Парі
Ассистанс Пюблик-Опито Де Пари
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофі - Сінтелабо, Санофи-Синтелабо, Ассістанс Пюблік-Опіто Де Парі, Ассистанс Пюблик-Опито Де Пари filed Critical Санофі - Сінтелабо
Publication of UA41446C2 publication Critical patent/UA41446C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UA97094765A 1995-03-27 1996-03-26 Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі UA41446C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27
PCT/FR1996/000448 WO1996030010A2 (fr) 1995-03-27 1996-03-26 Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales

Publications (1)

Publication Number Publication Date
UA41446C2 true UA41446C2 (uk) 2001-09-17

Family

ID=9477436

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97094765A UA41446C2 (uk) 1995-03-27 1996-03-26 Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі

Country Status (25)

Country Link
US (1) US5900431A (is)
EP (1) EP0817626B1 (is)
JP (1) JP3260378B2 (is)
KR (1) KR100286920B1 (is)
CN (1) CN1072485C (is)
AP (1) AP646A (is)
AT (1) ATE172641T1 (is)
AU (1) AU706161B2 (is)
CA (1) CA2216623C (is)
CZ (1) CZ286821B6 (is)
DE (1) DE69600879T2 (is)
DK (1) DK0817626T3 (is)
EA (1) EA000150B1 (is)
ES (1) ES2128846T3 (is)
FR (1) FR06C0014I2 (is)
HU (1) HU224028B1 (is)
IS (1) IS2048B (is)
NO (1) NO315968B1 (is)
NZ (1) NZ304906A (is)
OA (1) OA10515A (is)
PL (1) PL183378B1 (is)
SK (1) SK283883B6 (is)
TR (1) TR199701048T1 (is)
UA (1) UA41446C2 (is)
WO (1) WO1996030010A2 (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ304906A (en) * 1995-03-27 1999-06-29 Sanofi Sa Use of fumagillol or a fumagillol ester and an optionally saturated alkylcarboxylic or alkyldicarboxylic acid to fight intestinal infections
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
EP1156829B1 (fr) 1999-02-26 2007-05-09 Sanofi-Aventis Formulation stable contenant de la fumagilline
JP3265394B1 (ja) * 2001-03-14 2002-03-11 泰三 矢野 アクリル系樹脂手袋
DE10341887A1 (de) * 2003-09-09 2005-03-31 Leopold Kostal Gmbh & Co. Kg Elektrisches Schaltermodul
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques
MX2010005857A (es) * 2007-11-28 2010-11-22 Mersana Therapeutics Inc Conjugados de analogos de fumagillina biodegradables biocompatibles.
CN102123586A (zh) * 2008-07-18 2011-07-13 法弗根股份有限公司 治疗超重或肥胖受试者的方法
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
WO2010065877A2 (en) 2008-12-04 2010-06-10 Zafgen Corporation Methods of treating an overweight or obese subject
CN102639494B (zh) 2009-10-09 2016-11-09 扎夫根公司 砜化合物及其制备和使用方法
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
US8772333B2 (en) 2010-01-08 2014-07-08 Zafgen, Inc. Fumigillol type compounds and methods of making and using same
US20130266578A1 (en) 2010-04-07 2013-10-10 Thomas E. Hughes Methods of treating an overweight subject
JP5913310B2 (ja) 2010-07-22 2016-04-27 ザフゲン，インコーポレイテッド 三環式化合物ならびにその作製および使用方法
CN103347870A (zh) 2010-11-09 2013-10-09 扎夫根股份有限公司 Metap-2抑制剂的结晶固体及其制备和使用方法
WO2012075020A1 (en) 2010-11-29 2012-06-07 Zafgen Corporation Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
US9321740B2 (en) 2011-01-26 2016-04-26 Zafgen, Inc. Tetrazole compounds and methods of making and using same
MX342257B (es) 2011-03-08 2016-09-21 Zafgen Inc Derivados y análogos de oxaspiro [2.5] octano.
WO2012154679A1 (en) 2011-05-06 2012-11-15 Zafgen Corporation Tricyclic pyrazole sulfonamide compounds and methods of making and using same
WO2012154676A1 (en) 2011-05-06 2012-11-15 Zafgen Corporation Partially saturated tricyclic compounds and methods of making and using same
KR20140053013A (ko) 2011-05-06 2014-05-07 자프겐 인크. 삼환식 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
EP2763671A2 (en) 2011-10-03 2014-08-13 Zafgen, Inc. Methods of treating age related disorders
WO2013109735A1 (en) 2012-01-18 2013-07-25 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
EP2804866B1 (en) 2012-01-18 2016-11-16 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
EP2847176A1 (en) 2012-05-07 2015-03-18 Zafgen, Inc. Polymorphic salt of the oxalate salt of 6 - o - ( 4 - dimethylaminoethoxy) cinnarnoyl fumagillol and methods of making and using same
BR112014028041A2 (pt) 2012-05-08 2017-06-27 Zafgen Inc tratamento de obesidade hipotalâmica com inibidores de metap2
WO2013169860A1 (en) 2012-05-09 2013-11-14 Zafgen, Inc. Fumigillol type compounds and methods of making and using same
AU2013337287B2 (en) 2012-11-05 2017-03-23 Zafgen, Inc. Methods of treating liver diseases
AU2013337282A1 (en) 2012-11-05 2015-05-21 Zafgen, Inc. Tricyclic compounds and methods of making and using same
JP2015536983A (ja) 2012-11-05 2015-12-24 ザフゲン，インコーポレイテッド 肥満の治療及び抑制における三環式化合物の使用
BR112015023390A2 (pt) 2013-03-14 2017-07-18 Zafgen Inc métodos para tratar de doença renal e outros distúrbios
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
CN106591389B (zh) * 2015-10-15 2019-10-11 中国科学院微生物研究所 一种利用烟曲霉菌生产烟曲霉素的方法
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
JPH0629278B2 (ja) * 1985-06-26 1994-04-20 藤沢薬品工業株式会社 オキサスピロオクタン化合物
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
NZ304906A (en) * 1995-03-27 1999-06-29 Sanofi Sa Use of fumagillol or a fumagillol ester and an optionally saturated alkylcarboxylic or alkyldicarboxylic acid to fight intestinal infections
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
WO1998005293A2 (en) * 1996-08-02 1998-02-12 The Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors

Also Published As

Publication number Publication date
NO315968B1 (no) 2003-11-24
WO1996030010A3 (fr) 1996-11-28
DK0817626T3 (da) 1999-07-12
US5900431A (en) 1999-05-04
KR100286920B1 (ko) 2001-04-16
CN1072485C (zh) 2001-10-10
NO974466D0 (no) 1997-09-26
HU224028B1 (hu) 2005-05-30
DE69600879T2 (de) 1999-06-02
HUP9801220A3 (en) 2001-10-29
CN1179715A (zh) 1998-04-22
PL183378B1 (pl) 2002-06-28
JPH11506421A (ja) 1999-06-08
TR199701048T1 (xx) 1998-01-21
SK283883B6 (sk) 2004-04-06
CZ304997A3 (en) 1997-12-17
EP0817626B1 (fr) 1998-10-28
CA2216623A1 (en) 1996-10-03
AU5278696A (en) 1996-10-16
FR06C0014I2 (is) 2006-12-29
EA000150B1 (ru) 1998-10-29
AP9701092A0 (en) 1997-10-31
CA2216623C (en) 2005-05-31
OA10515A (fr) 2002-04-24
AU706161B2 (en) 1999-06-10
DE69600879D1 (de) 1998-12-03
CZ286821B6 (en) 2000-07-12
EA199700267A1 (ru) 1998-04-30
IS4557A (is) 1997-09-11
HUP9801220A2 (hu) 1999-09-28
KR19980703271A (ko) 1998-10-15
EP0817626A2 (fr) 1998-01-14
MX9707150A (es) 1998-07-31
JP3260378B2 (ja) 2002-02-25
IS2048B (is) 2005-09-15
ES2128846T3 (es) 1999-05-16
ATE172641T1 (de) 1998-11-15
FR06C0014I1 (is) 2006-11-17
SK130797A3 (en) 1998-03-04
NZ304906A (en) 1999-06-29
AP646A (en) 1998-04-27
WO1996030010A2 (fr) 1996-10-03
NO974466L (no) 1997-09-26
PL322470A1 (en) 1998-02-02

Similar Documents

Publication Publication Date Title
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
GR3037073T3 (en) Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
AP9801235A0 (en) Erythromycin derivatives.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
WO1990003172A3 (en) Bile acids for treatment of viral infections
DE19680202D2 (de) Arzneistoffe zur selektiven Bekämpfung von Tumorgewebe
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina